相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predictive features of ligand-specific signaling through the estrogen receptor
Jerome C. Nwachukwu et al.
MOLECULAR SYSTEMS BIOLOGY (2016)
Evaluation of the pharmacological activities of RAD1901, a selective estrogen receptor degrader
Suzanne E. Wardell et al.
ENDOCRINE-RELATED CANCER (2015)
Identification of GDC-0810 (ARN-810), an Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) that Demonstrates Robust Activity in Tamoxifen-Resistant Breast Cancer Xenografts
Andiliy Lai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Estrogen receptor a inhibitor activates the unfolded protein response, blocks protein synthesis, and induces tumor regression
Neal D. Andruska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER plus mammospheres
I. Kastrati et al.
ONCOGENE (2015)
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
Rinath Jeselsohn et al.
CLINICAL CANCER RESEARCH (2014)
Understanding response and resistance to oestrogen deprivation in ER-positive breast cancer
N. Patani et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network
Jerome C. Nwachukwu et al.
ELIFE (2014)
Bazedoxifene Exhibits Antiestrogenic Activity in Animal Models of Tamoxifen-Resistant Breast Cancer: Implications for Treatment of Advanced Disease
Suzanne E. Wardell et al.
CLINICAL CANCER RESEARCH (2013)
The AF-1 Activation Function of Estrogen Receptor α Is Necessary and Sufficient for Uterine Epithelial Cell Proliferation In Vivo
Anne Abot et al.
ENDOCRINOLOGY (2013)
Nuclear receptors in inflammation control: Repression by GR and beyond
Yurii Chinenov et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Ligand-binding dynamics rewire cellular signaling via estrogen receptor-α
Sathish Srinivasan et al.
NATURE CHEMICAL BIOLOGY (2013)
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Weiyi Toy et al.
NATURE GENETICS (2013)
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
Dan R. Robinson et al.
NATURE GENETICS (2013)
Improved Crystallographic Structures Using Extensive Combinatorial Refinement
Jerome C. Nwachukwu et al.
STRUCTURE (2013)
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
Shunqiang Li et al.
CELL REPORTS (2013)
Handling ligands with Coot
Judit E. Debreczeni et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2012)
Development of Selective Estrogen Receptor Modulator (SERM)-Like Activity Through an Indirect Mechanism of Estrogen Receptor Antagonism: Defining the Binding Mode of 7-Oxabicyclo[2.2.1]hept-5-ene Scaffold Core Ligands
Yangfan Zheng et al.
CHEMMEDCHEM (2012)
Hazard of Breast Cancer-Specific Mortality among Women with Estrogen Receptor-Positive Breast Cancer after Five Years from Diagnosis: Implication for Extended Endocrine Therapy
Ke-Da Yu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
HDX Workbench: Software for the Analysis of H/D Exchange MS Data
Bruce D. Pascal et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2012)
Phosphorylation by p38 Mitogen-Activated Protein Kinase Promotes Estrogen Receptor α Turnover and Functional Activity via the SCFSkp2 Proteasomal Complex
Shweta Bhatt et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Bicyclic core estrogens as full antagonists: synthesis, biological evaluation and structure-activity relationships of estrogen receptor ligands based on bridged oxabicyclic core arylsulfonamides
Manghong Zhu et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes
Vanessa Delfosse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Presenting your structures: the CCP4mg molecular-graphics software
S. McNicholas et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy
Suzanne E. Wardell et al.
BIOCHEMICAL PHARMACOLOGY (2011)
The Phenix software for automated determination of macromolecular structures
Paul D. Adams et al.
METHODS (2011)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Anti-breast cancer potential of SS1020, a novel antiestrogen lacking estrogenic and genotoxic actions
Y. R. Santosh Laxmi et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Coupling of receptor conformation and ligand orientation determine graded activity
John B. Bruning et al.
NATURE CHEMICAL BIOLOGY (2010)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
The transactivating function 1 of estrogen receptor α is dispensable for the vasculoprotective actions of 17β-estradiol
Audrey Billon-Gales et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CBP is a dosage-dependent regulator of nuclear factor-κB suppression by the estrogen receptor
Kendall W. Nettles et al.
MOLECULAR ENDOCRINOLOGY (2008)
NFκB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses
Kendall W. Nettles et al.
NATURE CHEMICAL BIOLOGY (2008)
Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators
Bryan M. Wittmann et al.
CANCER RESEARCH (2007)
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Ian W. Davis et al.
NUCLEIC ACIDS RESEARCH (2007)
Structural plasticity in the oestrogen receptor ligand-binding domain
Kendall W. Nettles et al.
EMBO REPORTS (2007)
Raloxifene and ICI182,780 increase estrogen receptor-α association with a nuclear compartment via overlapping sets of hydrophobic amino acids in activation function 2 helix 12
Mathieu Lupien et al.
MOLECULAR ENDOCRINOLOGY (2007)
Improving digestion efficiency under H/D exchange conditions with activated pepsinogen coupled columns
Scott A. Busby et al.
INTERNATIONAL JOURNAL OF MASS SPECTROMETRY (2007)
Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients
Lisa K. Dunnwald et al.
BREAST CANCER RESEARCH (2007)
Endocrine therapy resistance can be associated with high estrogen receptor α (ERα) expression and reduced ERα phosphorylation in breast cancer models
Barbara Kuske et al.
ENDOCRINE-RELATED CANCER (2006)
HKL-3000:: the integration of data reduction and structure solution -: from diffraction images to an initial model in minutes
Wladek Minor et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression
A Cvoro et al.
MOLECULAR CELL (2006)
Probing protein ligand interactions by automated hydrogen/deuterium exchange mass spectrometry
MJ Chalmers et al.
ANALYTICAL CHEMISTRY (2006)
Structural basis for an unexpected mode of SERM-mediated ER antagonism
YL Wu et al.
MOLECULAR CELL (2005)
Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter
L Cicatiello et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter
R Métivier et al.
CELL (2003)
Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) α activity by ERβ in the uterus
J Frasor et al.
ENDOCRINOLOGY (2003)
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
G Dontu et al.
GENES & DEVELOPMENT (2003)
The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-α and essential for the anti proliferative activity of ICI 182,780 in ERα-positive breast cancer cells
MY Fan et al.
MOLECULAR ENDOCRINOLOGY (2003)
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism
AK Shiau et al.
NATURE STRUCTURAL BIOLOGY (2002)
Structural insights into the mode of action of a pure antiestrogen
ACW Pike et al.
STRUCTURE (2001)
分享论文
